Trivia is not trivial for one club at the University of Pennsylvania.
WHO: James McGann, director, University of Pennsylvania Think Tanks and Civil Societies Program, and senior lecturer, Lauder Institute
Penn Pioneer in Personalized Medicine Advocates that National Translational Medicine Consortia is Best Equipped to Drive Human Phenotyping for the Clinic
President Barack Obama launched the "Precision Medicine Initiative” this past winter during the State of the Union address, and politicians on both sides of the aisle applauded the announcement. Broadly, precision medicine is meant to help diagnose individuals more accurately and better tailor treatment according to their physiology.
Two Researchers from Penn's Perelman School of Medicine Elected to American Academy of Arts and Sciences
Two researchers from the Perelman School of Medicine at the University of Pennsylvania have been elected as new members to the American Academy of Arts and Sciences, one of the nation's most prestigious honorary societies and a leading center for independent policy research.
University of Pennsylvania Team Receive Prestigious National Clinical Research Award for HIV Breakthrough
Researchers from the Perelman School of Medicine at the University of Pennsylvania and the Penn Center for AIDS Research (CFAR) are among the 2015 recipients of the prestigious Clinical Research Achievement Award for their personalized gene therapy work in HIV.
Eugenie Birch, co-director of the University of Pennsylvania's Institute for Urban Research, has been elected as the first president of the new General Assembly of Partners (GAP), a special initiative of the United Nation’s World Urban Campaign. Birch was elected at the GAP’s inaugural meeting, held in Nairobi, Kenya in mid-April.
Like a beloved pair of jeans, human DNA accumulates damage over time, and older people’s bodies can’t repair it as well. Many scientists believe a build up of damage can cause cells to enter an irreversible dormant state known as senescence.
Two Penn Medicine Studies Examine Diabetes Severity in Parkinson's, Sex Differences in Parkinson's Disease Caregiving
A pair of studies from the Perelman School of Medicine at the University of Pennsylvania demonstrate a correlation between diabetes severity and parkinsonism, or parkinsonian tremors; and examine the caregiving differences between men and women with PD.
Penn Study Shows Computer-Assisted Diagnosis Tool Helps Physicians Assess Skin Conditions Without Aid from Dermatologists
In the first major study to examine the use of a computer-assisted, photo-driven differential diagnosis generator for skin conditions, researchers at the Perelman School of Medicine at the University
The brain is a privileged organ in the body. So vital to life, the brain is protected from alterations elsewhere in the body by a highly regulated gateway known as the blood-brain barrier, which allows only selected molecules to pass through.
(This is the fourth in a series of features introducing the inaugural Penn President’s Engagement Prize winners.)
One in five patients discharged from the hospital experience an adverse event at home within three weeks. They may fall or mix up their medications, placing an extreme burden on their caregivers. Ultimately they’re readmitted to the hospital.
Abramson Cancer Center Gene Therapy Researcher Carl June, MD, to Receive AACR-CRI Lloyd J. Old Award in Cancer Immunology
Carl June, MD, the Richard W.
Plasma Ap0A1 Associates with Age at Onset and Motor Severity in Early Parkinson’s Disease Patients, Penn Medicine Researchers Find
Building on previous research showing that plasma Apolipoprotein A1 (ApoA1) may be a useful biomarker for Parkinson’s disease, researchers from the Perelman School of Medicine at the Universit
Penn Medicine Researchers Introduce New Brain Mapping Model Which Could Improve Effectiveness of Transcranial Magnetic Stimulation
Brain researchers from the Perelman School of Medicine at the University of Pennsylvania have developed a new brain mapping
Immunotherapy Drug Pembrolizumab Shows Early Promise for Mesothelioma Patients, Penn Medicine Researchers Find
The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma, a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall, according to a new study from researchers in the
New Combination of Immunotherapy Drugs is Safe, Shrinks Tumors in Metastatic Melanoma Patients, Penn Study Finds
Once again, researchers at Penn’s Abramson Cancer Center have extended the reach of the immune system in the fight against metastatic melanoma, this time by combining the checkpoint inhibitor tremelimumab with an anti-CD40 monoclonal antibody drug.
Penn Medicine: Investigational Personalized Cellular Therapy Tolerated Well by Patients with Advanced Mesothelioma, Ovarian and Pancreatic Cancers
Genetically modified versions of patients’ own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancreatic and ovarian cancers at the Per
RNA is both the bridge between DNA and the production of proteins that carry out the functions of life and what guides which and how much protein gets made.
Two Different Carotid Artery Stenting Procedures Show Little Difference in Effectiveness, According to Penn Medicine Study
Use of either proximal embolic protection devices (P-EPDs) or distal filter embolic protection devices (F-EPDs) during elective carotid artery stenting results in low rates of in-hospital stroke and death, according to a new study from researchers at the